The global clinical next-generation sequencing (NGS) market, valued at USD 6.2 billion in 2024, is expected to reach USD 15.2 billion by 2032 with a 13.6% CAGR. Growth drivers include personalized ...

Global next generation sequencing market was valued at $10.28 billion in 2021, and it is expected to reach a value of $33.73 billion by 2028, at a CAGR of 18.50% over the forecast period (2022 ...

Next Generation Sequencing webinar series this September. Learn WGS, exome, RNA sequencing, tips, and troubleshooting from experts.

The Centers for Medicare and Medicaid Services is now covering Food and Drug Administration approved or cleared laboratory diagnostic tests using Next Generation Sequencing for patients with inherited ...

The rapid evolution of HIV under antiretroviral pressure necessitates ongoing surveillance of drug resistance mutations. Next-generation sequencing (NGS) has emerged as a transformative technology ...

Aligned with this mission, MGI is proud to highlight the DNBSEQ™ platform for the next generation of highfidelity DNA sequencing.